In RA, No Added Second Malignancy Risk With Biologics
Some physicians have shown reluctance to use these agents for patients who have rheumatoid arthritis and a previous cancer diagnosis.
Source: ConsultantLive - Category: Internal Medicine Authors: Mariah Zebrowski Leach, JD, MS Tags: Rheumatoid Arthritis Source Type: news
More News: Arthritis | Cancer | Cancer & Oncology | Internal Medicine | Rheumatoid Arthritis | Rheumatology